Cargando…
Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer
BACKGROUND: Thymosin beta 10 (TMSB10) has been demonstrated to be involved in the malignant process of many cancers. The purpose of this study was to determine the biological roles and clinical significance of TMSB10 in breast cancer and to identify whether TMSB10 might be used as a serum marker for...
Autores principales: | Zhang, Xin, Ren, Dong, Guo, Ling, Wang, Lan, Wu, Shu, Lin, Chuyong, Ye, Liping, Zhu, Jinrong, Li, Jun, Song, Libing, Lin, Huanxin, He, Zhenyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299657/ https://www.ncbi.nlm.nih.gov/pubmed/28179017 http://dx.doi.org/10.1186/s13058-016-0785-2 |
Ejemplares similares
-
Thymosin Beta 4 and Thymosin Beta 10 Expression in Hepatocellular Carcinoma
por: Theunissen, W., et al.
Publicado: (2014) -
Immunoreactivity for Thymosin Beta 4 and Thymosin Beta 10 in the Adult Rat Oro-Gastro-Intestinal tract
por: Nemolato, S, et al.
Publicado: (2013) -
Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition
por: Ye, Liping, et al.
Publicado: (2016) -
The Clinical Relevance and Functional Implications of Thymosin Beta-10 in Glioma
por: Li, Weimin, et al.
Publicado: (2023) -
Preliminary findings on the expression of thymosin beta-10 in human breast cancer.
por: Verghese-Nikolakaki, S., et al.
Publicado: (1996)